Luteal Phase Support During Frozen Embryo Transfer Cycle
Status:
Completed
Trial end date:
2019-04-30
Target enrollment:
Participant gender:
Summary
We aimed to decrease quantity of exogenous estrogen and evaluated the success rate of ongoing
pregnancy in women undergone artificial FET who have a surplus embryos at previous fertility
treatment cycles.
In this study, endometrial prepared with standard long GnRH protocol and for luteal phase
support patients received 6 mg oral E2 and intramuscularly P 100 mg/d and embryos on day 2-3
were transferred. Control group continued E2 until 12 week of pregnancy, while for cases
after identify gestational sac with heart beat (the 6 week of pregnancy) by vaginal
ultrasonography, E2 will discontinued.